Iranian Journal of Pediatrics

Published by: Kowsar

Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Parsa Yousefichaijan 1 , Ali Cyrus 2 , Fatemeh Dorreh 3 , Mohammad Rafeie 4 , Mojtaba Sharafkhah 5 , * , Faryar Frohar 1 and Fatemeh Safi 6
Authors Information
1 Department of Pediatric Nephrology, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
2 Department of Surgery, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
3 Department of Pediatrics, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
4 Department of Biostatistics and Epidemiology, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
5 Students Research Committee, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
6 Department of Radiology, School of Medicine, Arak University of Medical Sciences, Arak, IR Iran
Article information
  • Iranian Journal of Pediatrics: December 28, 2015, 25 (6); e1445
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: March 13, 2015
  • Accepted: August 22, 2015
  • DOI: 10.5812/ijp.1445

To Cite: Yousefichaijan P, Cyrus A, Dorreh F, Rafeie M, Sharafkhah M, et al. Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Iran J Pediatr. 2015 ; 25(6):e1445. doi: 10.5812/ijp.1445.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Naseri M, Varasteh AR, Alamdaran SA. Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis. 2010; 4(1): 32-8
  • 2. Edvardsson V, Elidottir H, Indridason OS, Palsson R. High incidence of kidney stones in Icelandic children. Pediatric Nephrol. 2005; 20(7): 940-4[DOI]
  • 3. Naseri M, Sadeghi R. Role of high-dose hydrochlorothiazide in idiopathic hypercalciuric urolithiasis of childhood. Iran J Kidney Dis. 2011; 5(3): 162-8
  • 4. Vahlensieck EW, Bach D, Hesse A. Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res. 1982; 10(4)[DOI]
  • 5. Borghi L, Ferretti PP, Elia GF, Amato F, Melloni E, Trapassi MR, et al. Epidemiological Study of Urinary Tract Stones in a Northern Italian City. Br J Urol. 1990; 65(3): 231-5[DOI]
  • 6. Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, et al. Pediatric Urolithiasis. Scandinavian J Urol Nephrol. 2003; 37(2): 129-33[DOI]
  • 7. Gearhart JP, Herzberg GZ, Jeffs RD. Childhood uro lithiasis: experiences and advances. Pediatrics . 1991; 87: 445-50
  • 8. Noe HN, Stapleton FB, Jerkins GR, Roy S. Clinical experience with pediatric urolithiasis. J Urol . 1983; 129: 1166-8
  • 9. Milliner DS, Murphy ME. Urolithiasis in Pediatric Patients. Mayo Clinic Proceedings. 1993; 68(3): 241-8[DOI]
  • 10. McKay CP. Renal Stone Disease. Pediatr Rev. 2010; 31(5): 179-88[DOI]
  • 11. Copelovitch L. Urolithiasis in Children. Pediatr Clin North Am. 2012; 59(4): 881-96[DOI]
  • 12. Peres LAB, Langer SS, Schmidt RC, Nacke RAB, Francescon PVM, Almeida RCD, et al. Nefrolitíase em pacientes pediátricos: investigação metabólica e anatômica. J Brasileiro de Nefrologia. 2011; 33(1): 50-4[DOI]
  • 13. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in Pediatric Patients: A Single Center Study of Incidence, Clinical Presentation and Outcome. J Urol. 2007; 177(6): 2300-5[DOI]
  • 14. Coward RJ, Peters CJ, Duffy PG, Corry D, Kellett MJ, Choong S, et al. Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child. 2003; 88(11): 962-5[PubMed]
  • 15. Rangnekar GV, Gaur MS. Serum and Urinary Zinc Levels in Urolithiasis. Br J Urol. 1993; 71(5): 527-9[DOI]
  • 16. Chi T. Research identifies important role of zinc in kidney stone. Paper presented at the Genetics Society of America's 54th Annual Drosophila Conference. 2013;
  • 17. Atakan IH, Kaplan M, Seren G, Aktoz T, Gül H, Inci O. Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int Urol Nephrol. 2007; 39(2): 351-6[DOI]
  • 18. Trinchieri A, Mandressi A, Luongo P, Rovera F, Longo G. Urinary Excretion of Citrate, Glycosaminoglycans, Magnesium and Zinc in Relation to Age and Sex in Normal Subjects and in Patients who form Calcium Stones. Scandinavian J Urol Nephrol. 1992; 26(4): 379-86[DOI]
  • 19. Komleh K, Hada P, Pendse AK, Singh PP. Zine, copper and manganese in serum, urine and stones. Int Urol Nephrol. 1990; 22(2): 113-8[DOI]
  • 20. Ozgurtas T, Yakut G, Gulec M, Serdar M, Kutluay T. Role of Urinary Zinc and Copper on Calcium Oxalate Stone Formation. Urologia Int. 2004; 72(3): 233-6[DOI]
  • 21. Elder JS. Nelson Text Book of Pediatrics. 2011; : 1864-186400000000[DOI]
  • 22. Spivacow FR, Negri AL, del Valle EE, Calviño I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol. 2008; 23(7): 1129-33[DOI]
  • 23. Saper RB, Rash R. Zinc: an essential micronutrient. Am Fam Physician. 2009; 79(9): 768-72[PubMed]
  • 24. Krebs NF, Primak LE. Nelson Essentials of Pediatrics. 2010;
  • 25. Greenbaum LA. Micronutrient Mineral Deficiencies. 2011; : 211-211000[DOI]
  • 26. Yousefi P, Firouzifar M, Cyrus A. Does hydrochlorothiazide prevent recurrent urinary tract infection in children with idiopathic hypercalciuria? J Pediatr Urol. 2013; 9(6): 775-8[DOI]
  • 27. Durak I, Kilic Z, Sahin A, Akpoyraz M. Analysis of calcium, iron, copper and zinc contents of nucleus and crust parts of urinary calculi. Urol Res. 1992; 20(1): 23-6[DOI]
  • 28. Perk H, Serel T, ar A, Deniz N, et al. Analysis of the Trace Element Contents of Inner Nucleus and Outer Crust Parts of Urinary Calculi. Urologia Internationalis. 2002; 68(4): 286-90[DOI]
  • 29. Bazin D, Chevallier P, Matzen G, Jungers P, Daudon M. Heavy elements in urinary stones. Urol Res. 2007; 35(4): 179-84[DOI][PubMed]
  • 30. Hesse A, Dietze HJ, Berg W, Hienzsch E. Mass spectrometric trace element analysis of calcium oxalate uroliths. Eur Urol . 1977; 3: 359-61
  • 31. Levinson AA, Nosal M, Davidman M. Trace elements in kidney stones from three areas in the United States. Invest Urol. 1978; 15: 270-4
  • 32. Joost J, Tessadri R. Trace element investigations in kidney stone patients. Eur Urol. 1987; 13(4): 264-70[PubMed]
  • 33. Sutor D. Growth Studies of Calcium Oxalate in the Presence of Various Ions and Compounds. Br J Urol. 1969; 41(2): 171-8[DOI]
  • 34. Grases F, Genestar C, Millán A. The influence of some metallic ions and their complexes on the kinetics of crystal growth of calcium oxalate. J Crystal Growth. 1989; 94(2): 507-12[DOI]
  • 35. Cohanim M, Yendt ER. The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med J. 1975; 136(3): 137-41[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments